Tamura Takao相关文献与解析，生知库 | 链接生命科学的每一步

Takashi Kondo # ，Rigel Suzuki # ，Hisano Yajima # ，Sachiho Kawahara ，Kodai Yamaya ，Takaya Ichikawa ，Shuhei Tsujino ，Saori Suzuki ，Tomokazu Tamura ，Takao Hashiguchi ，Takasuke Fukuhara

ACE2

炎症/感染

SARS-CoV-2

发表日期：2025

文献求助收藏

Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer

TRUSTY研究中利用血浆血管生成相关因子和游离DNA进行探索性生物标志物分析：一项随机、II/III期研究，评估三氟尿苷/替吡嘧啶联合贝伐珠单抗作为转移性结直肠癌二线治疗的疗效

期刊:Targeted Oncology

影响因子:4

doi:10.1007/s11523-023-01027-8

Sunakawa, Yu; Kuboki, Yasutoshi; Watanabe, Jun; Terazawa, Tetsuji; Kawakami, Hisato; Yokota, Mitsuru; Nakamura, Masato; Kotaka, Masahito; Sugimoto, Naotoshi; Ojima, Hitoshi; Oki, Eiji; Kajiwara, Takeshi; Yamamoto, Yoshiyuki; Tsuji, Yasushi; Denda, Tadamichi; Tamura, Takao; Ishihara, Soichiro; Taniguchi, Hiroya; Nakajima, Takako Eguchi; Morita, Satoshi; Shirao, Kuniaki; Takenaka, Naruhito; Ozawa, Daisuke; Yoshino, Takayuki

Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan

日本一项多中心回顾性研究显示，在接受纳武利尤单抗治疗的三线或后续化疗期间，晚期胃癌患者的疾病进展模式与预后不良相关。

期刊:Gastric Cancer

影响因子:5.1

doi:10.1007/s10120-022-01349-y

Aoki, Masahiko; Kadowaki, Shigenori; Takahashi, Naoki; Suzuki, Takeshi; Oshima, Kotoe; Ando, Takayuki; Yamamoto, Yoshiyuki; Kawakami, Kentaro; Kito, Yosuke; Matsumoto, Toshihiko; Shimozaki, Keitaro; Miyazaki, Yasuhiro; Yamaguchi, Toshifumi; Nagase, Michitaka; Tamura, Takao; Amanuma, Yusuke; Esaki, Taito; Miura, Yuji; Akiyoshi, Kohei; Baba, Eishi; Makiyama, Akitaka; Negoro, Yuji; Nakashima, Koji; Sugimoto, Naotoshi; Nagashima, Kengo; Shoji, Hirokazu; Boku, Narikazu

Role of debulking surgery in combination with immune therapy: A successfully treated case of locally advanced mucosal melanoma

减瘤手术联合免疫疗法的作用：一例局部晚期黏膜黑色素瘤成功治疗病例

期刊:Molecular and Clinical Oncology

影响因子:1.4

doi:10.3892/mco.2021.2435

Kimura, Takahiro; Takahama, Takayuki; Wakasa, Tomoko; Adachi, Shiori; Akashi, Yusaku; Tamura, Takao; Yane, Katsunari

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab

纳武利尤单抗治疗既往接受过治疗的晚期胃癌（ATTRACTION-2）：3 年更新及纳武利尤单抗治疗进展后的疗效

期刊:Gastric Cancer

影响因子:5.1

doi:10.1007/s10120-021-01173-w

Boku, Narikazu; Satoh, Taroh; Ryu, Min-Hee; Chao, Yee; Kato, Ken; Chung, Hyun Cheol; Chen, Jen-Shi; Muro, Kei; Kang, Won Ki; Yeh, Kun-Huei; Yoshikawa, Takaki; Oh, Sang Cheul; Bai, Li-Yuan; Tamura, Takao; Lee, Keun-Wook; Hamamoto, Yasuo; Kim, Jong Gwang; Chin, Keisho; Oh, Do-Youn; Minashi, Keiko; Cho, Jae Yong; Tsuda, Masahiro; Nishiyama, Taihei; Chen, Li-Tzong; Kang, Yoon-Koo

Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)

瑞戈非尼与三氟尿苷/替吡嘧啶盐酸盐交叉给药治疗转移性结直肠癌患者的生存获益：日本结直肠癌学会多中心观察性研究（REGOTAS）的探索性分析

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2021.576036

Chida, Keigo; Kotani, Daisuke; Moriwaki, Toshikazu; Fukuoka, Shota; Masuishi, Toshiki; Takashima, Atsuo; Kumekawa, Yosuke; Kajiwara, Takeshi; Yamazaki, Kentaro; Komoda, Masato; Makiyama, Akitaka; Denda, Tadamichi; Hatachi, Yukimasa; Suto, Takeshi; Sugimoto, Naotoshi; Enomoto, Masanobu; Ishikawa, Toshiaki; Kashiwada, Tomomi; Ando, Koji; Yuki, Satoshi; Okita, Yoshihiro; Kusaba, Hitoshi; Sakai, Daisuke; Okamoto, Koichi; Tamura, Takao; Yamashita, Kimihiro; Gosho, Masahiko; Shimada, Yasuhiro

Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment

原发肿瘤位置对接受瑞戈非尼或三氟尿苷/替吡嘧啶二线治疗的转移性结直肠癌患者的临床影响

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2021.688709

Nakajima, Hiromichi; Fukuoka, Shota; Masuishi, Toshiki; Takashima, Atsuo; Kumekawa, Yosuke; Kajiwara, Takeshi; Yamazaki, Kentaro; Negoro, Yuji; Komoda, Masato; Makiyama, Akitaka; Denda, Tadamichi; Hatachi, Yukimasa; Suto, Takeshi; Sugimoto, Naotoshi; Enomoto, Masanobu; Ishikawa, Toshiaki; Kashiwada, Tomomi; Ando, Koji; Yuki, Satoshi; Okuyama, Hiroyuki; Kusaba, Hitoshi; Sakai, Daisuke; Okamoto, Koichi; Tamura, Takao; Yamashita, Kimihiro; Gosho, Masahiko; Moriwaki, Toshikazu

Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial

日本晚期胃癌患者接受雷莫芦单抗治疗的生活质量：来自 III 期 RAINBOW 试验的探索性分析

期刊:Clinical Drug Investigation

影响因子:2.7

doi:10.1007/s40261-020-00979-3

Yamaguchi, Kensei; Shimada, Yasuhiro; Hironaka, Shuichi; Sugimoto, Naotoshi; Komatsu, Yoshito; Nishina, Tomohiro; Omuro, Yasushi; Tamura, Takao; Piao, Yongzhe; Homma, Gosuke; Jen, Min-Hua; Liepa, Astra M; Muro, Kei

Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer

ATTRACTION-2试验中既往接受过曲妥珠单抗治疗的患者探索性亚组分析：一项随机III期临床试验，旨在研究纳武利尤单抗治疗晚期胃癌/胃食管交界处癌患者的疗效和安全性

期刊:Gastric Cancer

影响因子:5.1

doi:10.1007/s10120-019-00970-8

Satoh, Taroh; Kang, Yoon-Koo; Chao, Yee; Ryu, Min-Hee; Kato, Ken; Cheol Chung, Hyun; Chen, Jen-Shi; Muro, Kei; Ki Kang, Won; Yeh, Kun-Huei; Yoshikawa, Takaki; Oh, Sang Cheul; Bai, Li-Yuan; Tamura, Takao; Lee, Keun-Wook; Hamamoto, Yasuo; Kim, Jong Gwang; Chin, Keisho; Oh, Do-Youn; Minashi, Keiko; Cho, Jae Yong; Tsuda, Masahiro; Tanimoto, Mitsunobu; Chen, Li-Tzong; Boku, Narikazu

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

一项针对既往接受过治疗的晚期胃癌或胃食管交界处癌患者的纳武利尤单抗3期研究（ATTRACTION-2）：2年更新数据

期刊:Gastric Cancer

影响因子:5.1

doi:10.1007/s10120-019-01034-7

Chen, Li-Tzong; Satoh, Taroh; Ryu, Min-Hee; Chao, Yee; Kato, Ken; Chung, Hyun Cheol; Chen, Jen-Shi; Muro, Kei; Kang, Won Ki; Yeh, Kun-Huei; Yoshikawa, Takaki; Oh, Sang Cheul; Bai, Li-Yuan; Tamura, Takao; Lee, Keun-Wook; Hamamoto, Yasuo; Kim, Jong Gwang; Chin, Keisho; Oh, Do-Youn; Minashi, Keiko; Cho, Jae Yong; Tsuda, Masahiro; Sameshima, Hiroki; Kang, Yoon-Koo; Boku, Narikazu

Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2

小鼠ACE2对SARS-CoV-2感染易感性的决定因素

Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer

TRUSTY研究中利用血浆血管生成相关因子和游离DNA进行探索性生物标志物分析：一项随机、II/III期研究，评估三氟尿苷/替吡嘧啶联合贝伐珠单抗作为转移性结直肠癌二线治疗的疗效

Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan

日本一项多中心回顾性研究显示，在接受纳武利尤单抗治疗的三线或后续化疗期间，晚期胃癌患者的疾病进展模式与预后不良相关。

Role of debulking surgery in combination with immune therapy: A successfully treated case of locally advanced mucosal melanoma

减瘤手术联合免疫疗法的作用：一例局部晚期黏膜黑色素瘤成功治疗病例

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab

纳武利尤单抗治疗既往接受过治疗的晚期胃癌（ATTRACTION-2）：3 年更新及纳武利尤单抗治疗进展后的疗效

Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)

瑞戈非尼与三氟尿苷/替吡嘧啶盐酸盐交叉给药治疗转移性结直肠癌患者的生存获益：日本结直肠癌学会多中心观察性研究（REGOTAS）的探索性分析

Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment

原发肿瘤位置对接受瑞戈非尼或三氟尿苷/替吡嘧啶二线治疗的转移性结直肠癌患者的临床影响

Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial

日本晚期胃癌患者接受雷莫芦单抗治疗的生活质量：来自 III 期 RAINBOW 试验的探索性分析

Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer

ATTRACTION-2试验中既往接受过曲妥珠单抗治疗的患者探索性亚组分析：一项随机III期临床试验，旨在研究纳武利尤单抗治疗晚期胃癌/胃食管交界处癌患者的疗效和安全性

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

一项针对既往接受过治疗的晚期胃癌或胃食管交界处癌患者的纳武利尤单抗3期研究（ATTRACTION-2）：2年更新数据